logo

For the Inventor, By the Inventor

Tokyo-to, Japan

Otsuka Pharmaceutical Company, Limited


USPTO Granted Patents = 846



Trademarks = 140

Forward Citations = 6,650

Loading Chart...
Loading Chart...

1,285 inventors (with patents filed for the assignee):

goldMedal Michiaki Tominaga (79 out of 80 patents)

silverMedal Kazuyuki Nakagawa (67 out of 67 patents)

bronzeMedal Hiroshi Yamashita (34 out of 93 patents)

4.  Hidenori Ogawa (30 out of 30 patents)

5.  Yoichi Yabuuchi (29 out of 29 patents)

6.  Nobuaki Ito (27 out of 27 patents)

7.  Kazumi Kondo (27 out of 27 patents)

8.  Satoru Nakai (27 out of 27 patents)

9.  Takakuni Matsuda (25 out of 26 patents)

10.  Hisashi Miyamoto (25 out of 25 patents)

11.  Tetsuro Kikuchi (24 out of 25 patents)

12.  Takao Nishi (24 out of 25 patents)

13.  Takafumi Fujioka (24 out of 24 patents)

14.  Shin Miyamura (20 out of 20 patents)

15.  Naoto Utsumi (20 out of 21 patents)


Core Competencies:
SHP2 Phosphatase Inhibitors
Heterocyclic Compounds
Wearable Sensors
Pharmaceutical Formulations
Ocular Surface Tissue
Antitumor Composition
Ingestible Medical Devices
Protein Kinase Inhibitors
Therapeutic Regimens
Polycystic Kidney Disease
Surface Plasmon Resonance
Oral Administration

846 patents:

1. 12491148 - Adenosine phosphate-containing O/W type emulsion composition having low viscosity (2025-12-09),
2. 12458640 - Pyrazolo[3,4-b]pyrazine SHP2 phosphatase inhibitors (2025-11-04),
3. 12391674 - Heterocyclic compounds for the treatment of epilepsy (2025-08-19),
4. 12383181 - Elastic wearable sensor (2025-08-12),
5. 12370144 - Centanafadine pharmaceutical formulations, and methods of making and using same (2025-07-29),
6. 12365950 - Method of detecting conjunctival disease using ocular surface tissue, and aging biomarker (2025-07-22),
7. 12306106 - Detection device (2025-05-20),
8. 12274562 - Re-wearable physiological monitoring device (2025-04-14),
9. 12220410 - Antitumor composition (2025-02-11),
10. 12196674 - Detection device and detection method (2025-01-14),
11. 12195496 - 2'-deoxy-2′,2′-difluorotetrahydrouridines with high purity and methods of making the same (2025-01-14),
12. 12187757 - 2'-deoxy-2′,2′-difluorotetrahydrouridines with high purity and methods of making the same (2025-01-07),
13. 12186312 - Sleep improving agent (2025-01-07),
14. 12156941 - Centanafadine pharmaceutical formulations, and methods of making and using same (2024-12-03),
15. 12152232 - strain (2024-11-26),
Otsuka Pharmaceutical Company, Limited is a global healthcare company headquartered in Japan. They focus on the development, manufacture, and marketing of innovative pharmaceutical products, including prescription drugs, consumer healthcare products, and nutraceuticals. Otsuka aims to contribute to the well-being of people around the world through their commitment to creativity and creating unique value in healthcare.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

...
846 Patents

#1 in Tokyo-to

#250 in Japan

#1,159 in the World

...
Tokyo-to, Japan

Otsuka Pharmaceutical Company, Limited

Forward Citations = 6,650

1,285 inventors:

goldMedal Michiaki Tominaga (79 out of 80 patents)

silverMedal Kazuyuki Nakagawa (67 out of 67 patents)

bronzeMedal Hiroshi Yamashita (34 out of 93 patents)

4.  Hidenori Ogawa (30 out of 30 patents)

5.  Yoichi Yabuuchi (29 out of 29 patents)

Please report any incorrect information to support@idiyas.com
Loading…